The use of Quantiferon-TB gold in-tube test in screening latent tuberculosis among Saudi Arabia dialysis patients
- PMID: 26664568
- PMCID: PMC4652296
- DOI: 10.4103/1817-1737.157295
The use of Quantiferon-TB gold in-tube test in screening latent tuberculosis among Saudi Arabia dialysis patients
Abstract
Background and aim: Screening for tuberculosis (TB) is a key strategy for controlling infection. This study aimed to detect latent TB among dialysis patients.
Methods: This is a prospective study conducted in King Saud University, Riyadh involving hemodialysis (HD) and peritoneal dialysis (PD) patients aged ≥18 years. Patients were screened for latent TB infection (LTBI) using both TBskin test (TST) and QuantiFERONTB Gold In-Tube test (QFT-GIT). All participants were followed-up clinically and radiologically every 3 months for 2 years.
Results: A total of 243 (181 HD and 62 PD) patients were included and 112(46.1%) were males. 45.3% showed positive QFT in HD patients with sensitivity of 91.7%, specificity of 71.4%, positive predictive value (PPV) of 19.5%, and negative predictive value (NPV) of 91.1%. TST results in HD showed that positive TST was 17.4%, sensitivity was 63.2%, specificity was 95.5%, PPV was 51.5%, and NPV was 91.1%. Five (8.1%) showed positive QFT in PD patients with sensitivity of 7.7%, specificity of 91.8%, PPV of 6.6%, and NPV of 92.3%. TST results in PD showed that positive TST was 9.8%, sensitivity was 35.7%, specificity was 97.9%, PPV was 55.8%, and NPV was 93.3%. Previous TB infection was significantly correlated with QFT only in HD patients, but significantly associated with TST in both HD and PD patients. Also in HD, QFT was significantly associated with TST (P = 0.043).
Conclusions: Due to high variability of QFT-GIT sensitivity, we recommend its use for its NPV and to use either TST or QFT in screening latent TB.
Keywords: Dialysis; King Abdulaziz City of Science and Technology; King Saud University; quantiferon; tuberculosis.
Conflict of interest statement
Similar articles
-
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.Eur Respir J. 2009 Mar;33(3):586-93. doi: 10.1183/09031936.00107608. Epub 2008 Dec 1. Eur Respir J. 2009. PMID: 19047313
-
Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.Transpl Infect Dis. 2010 Apr;12(2):98-105. doi: 10.1111/j.1399-3062.2009.00469.x. Epub 2009 Nov 10. Transpl Infect Dis. 2010. PMID: 19903322
-
Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.Transplant Proc. 2013 Oct;45(8):2899-902. doi: 10.1016/j.transproceed.2013.08.059. Transplant Proc. 2013. PMID: 24157000
-
Performance of Current Diagnostic Tools in Detecting Latent Tuberculosis Among Healthcare Workers: A Systematic Review.Cureus. 2024 Oct 1;16(10):e70621. doi: 10.7759/cureus.70621. eCollection 2024 Oct. Cureus. 2024. PMID: 39483545 Free PMC article. Review.
-
[Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].Kekkaku. 2006 Nov;81(11):681-6. Kekkaku. 2006. PMID: 17154047 Review. Japanese.
Cited by
-
Prevalence of Latent Tuberculosis Infection among Patients Undergoing Regular Hemodialysis in Disenfranchised Communities: A Multicenter Study during COVID-19 Pandemic.Medicina (Kaunas). 2023 Mar 26;59(4):654. doi: 10.3390/medicina59040654. Medicina (Kaunas). 2023. PMID: 37109612 Free PMC article.
-
The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy.Ann Saudi Med. 2021 Sep-Oct;41(5):285-292. doi: 10.5144/0256-4947.2021.285. Epub 2021 Oct 7. Ann Saudi Med. 2021. PMID: 34618606 Free PMC article.
References
-
- Rook GA, Dheda K, Zumla A. Immune responses to tuberculosis in developing countries: Implications for new vaccines. Nat Rev Immunol. 2005;5:661–7. - PubMed
-
- Lienhardt C. From exposure to disease: The role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol Rev. 2001;23:288–301. - PubMed
-
- Meya DB, McAdam KP. The TB pandemic: An old problem seeking new solutions. J Intern Med. 2007;261:309–29. - PubMed
-
- al-Kassimi FA, Abdullah AK, al-Hajjaj MS, al-Orainey IO, Bamgboye EA, Chowdhury MN. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia. Tuber Lung Dis. 1993;74:254–60. - PubMed
-
- Al-Hajoj SA. Tuberculosis in Saudi Arabia: Can we change the way we deal with the disease? J Infect Public Health. 2010;3:17–24. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources